t
i n a
\
«Mi
S O M E
P E O P L E T A K I N G A N A N T I D E P R E S S A N T
S T IL L H A V E
U N R E S O L V E D S Y M P T O M S O F
D E P R E S S I O N .
I f y o u ’ r e
o n e
o f t h e m
,
t a l k t o y o u r d o c t o r .
Y o u r o p t i o n s m
a y i n c l u d e a d d i n g A B I L I F Y t o
t h e a n t i d e p r e s s a n t y o u ’ r e
a l r e a d y t a k i n g .
ABILIFY is the only medicine FDA-approved to treat depression in adults
when added to an antidepressant (such as Lexapro® Zoloft® Prozac®
Effexor XR® Paxil CR® or a generic equivalent).*
IMPORTANT SAFETY INFORMATION:
Elderly patients with dementia-related psychosis (eg, an inability to perform daily activities
duo to incroasod memory loss) taking ABILIFY have an increased risk of death or stroke. ABILIFY
is not approved for treating these patients.
Antidepressants can increase suicidal thoughts and behaviors in children, teens, and young adults.
Serious mental illnesses are themselves associated with an increase in the risk of suicide.
When taking ABILIFY call your doctor right away if you have new or worsening depression
symptoms, unusual changes in behavior, or thoughts of suicide. Patients and their caregivers
should be especially observant within the first few months of treatment or after a change in
dose. Approved only for adults 18 and over with depression.
•A le rt your doctor if you develop very high fever, rigid muscles, shaking, confusion, sweating, or
increased heart rate and blood pressure, as these may be signs of a rare but potentially fatal
condition called neuroleptic malignant syndrome (NMS)
• If you develop abnormal or uncontrollable facial movements, notify your doctor, as these may be
signs of tardive dyskinesia (TD), which could become permanent
• If you have diabetes or have risk factors or symptoms of diabetes, your blood sugar should be
monitored. High blood sugar has been reported with ABILIFY and medicines like it. In some cases,
extreme high blood sugar can lead to coma or death
• Other risks may include lightheadedness upon standing, seizures, trouble swallowing, or impairment
in judgment or motor skills. Until you know how ABILIFY affects you, you should not drive or operate
machinery
I he common side effects in adults in clinical trials (>10% ) include nausea, vomiting, constipation,
headache, dizziness, an inner sense of restlessness or need to move (akathisia), anxiety and insomnia.
Tell your doctor about all the medicines you’re taking, since there are some risks for drug interactions.
You should avoid alcohol while taking ABILIFY.
ADD-ON TREATMENT FOR
UNRESOLVED SYMPTOMS
OF DEPRESSION IN ADULTS
A B IL IF Y
2 mg, 5 mg Tablet
www.abillfy.com
If you
O
f someone you
know
n«ds hefp
piyinq
for mediant «*1
I -888-4PPA
-N0W
( I -888-4/7-2669) O
f i
)0
«0
www
ppanr O
f<
J
Partner ship for
PrrMriplion
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please read the Important Information about ABILIFY on the adjacent page.
* Lexapro'5 (escilalopiam uxalale). Zolull* (sertraline HCI), Prozac® (lluuxeline hydrochloride), tllexoi XR
(venlalaxine HU). Paxil CR* (paroxetine HU) aie trademarks ul their
raspficflvfi companlfts.
■ Bristol M yrrs Squibb
O tSU kû Olvukd Amwiw Pfwwwmitiuil.liK.
© z u u a Otsuka Am erica Pharmaceutical. Inc.
. Hockviiie. M U
O /U U SU öA ö iOUI L»
June 2UUö
U’J U ö A - n y z
Pnnted in U SA
